French Centifolia Rose Pistil Stem Cells
A Natural Reproductive Rejuvenator for the Modern Woman
28 Bottles of Liquid 7 Bottles of Powder
By purchasing this product, you earn 59 reward points.Learn more
* World-First Dual-Dose Formula
Developed by Australian Geekkit Health in collaboration with Stanford University, it is the first product globally designed to comprehensively support the female reproductive axis—ovaries, uterus and vagina—while also enhancing immunity and hormonal balance.
* Potent Botanical Concentration
Formulated with 17 rare botanicals, the active ingredient concentration exceeds the original formula by over 300%, delivering intensive nourishment, detoxification, and cellular support.
* Cycle-Synced Dual-Phase Delivery System
Featuring patented Cycle-Synced Technology™, the dual-phase system combines liquid and powder doses to align with a woman’s natural reproductive cycle—liquid for nutrient infusion during non-menstrual days, and powder for detoxification during menstruation.
* Clinically Validated Results
In a 28-day trial among women aged 20–50, participants experienced an average reduction in ovarian age by 5.01 years and biological age by 1.90 years, along with measurable improvements in uterine lining thickness and vaginal flora balance.
* Advanced Hormone Regulation
Patented estrogen-mimetic precursors help activate the body’s own hormonal regulation mechanisms, supporting natural hormone balance and revitalising ovarian function without adding external hormones.
* Comprehensive Cellular Protection
Ingredients such as PQQ, truffles, ergothioneine and selenium combat oxidative stress, neutralise free radicals, clear cellular waste, and strengthen immunity—helping to prevent gynaecological and urinary tract inflammation.
* Vaginal Ecology and Pelvic Floor Support
Damiana and probiotics contribute to a balanced vaginal microbiome, activate immune defences, and support pelvic floor health, promoting a more youthful vaginal environment and improved sexual wellbeing.
* Safe and Holistic Approach
Hormone-free, this formulation offers a natural, comprehensive solution to maintain reproductive health, delay ageing, and support overall vitality from the inside out.
Science, beauty and well-being
Professor Dean W. Felsher earned his Doctor of Medicine (MD) degree from the University of California, Los Angeles (UCLA) in 1992 and has held a long-standing academic position at Stanford University. Professor Felsher has participated in numerous research projects funded by the National Institutes of Health (NIH), covering a wide range of topics including clinical and molecular oncology, molecular carcinogenesis, cancer biology, and nanomedicine.
Currently, Professor Felsher serves on the editorial boards of several prestigious international journals, including *Cancer Biology & Therapy*, *The Journal of Clinical Investigation*, *Cancer Research*, *Haematological Oncology*, *The American Journal of Pathology*, *Pharmacogenomics Journal*, *Breast Cancer Research*, *The Lancet*, *Molecular Cancer Research*, *PLoS*, *Nature*, and *EMBO*, among others.
Professor Felsher emphasises: “Ageing is fundamentally the result of dysregulated coordination between gene expression, cellular function, and organ homeostasis. Our research has demonstrated that precise genetic interventions can effectively delay physiological ageing processes and reduce the risk of cardiovascular diseases, neurodegenerative conditions, and cancer.”
This scientific perspective establishes a robust academic foundation for his collaboration with GOVMY®.
As a flagship brand under Geekkit Health, GOVMY® holds a leading position in the Australian health supplement market. Backed by the group’s formidable scientific capabilities, GOVMY® translates cutting-edge gene technology into innovative anti-ageing solutions that have gained global recognition.
Professor Dean W. Felsher will be deeply involved in GOVMY®’s scientific research programs, contributing his extensive expertise in molecular biology to drive breakthroughs in anti-ageing mechanisms and product development.